Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte–endothelial cell signaling and JNK activation
- 371 Downloads
Inflammation and damage promote monocyte adhesion to endothelium and cardiovascular disease (CVD). Elevated inflammation and increased monocyte–endothelial cell interactions represent the initial stages of vascular remodeling associated with a multitude of CVDs. Cathepsins are proteases produced by both cell types that degrade elastin and collagen in arterial walls, and are upregulated in CVD. We hypothesized that the inflammatory cytokine tumor necrosis factor alpha (TNFα) and monocyte binding would stimulate cathepsins K and V expression and activity in endothelial cells that may be responsible for initiating local proteolysis during CVD. Confluent human aortic endothelial cells were stimulated with TNFα or THP-1 monocyte co-cultures, and multiplex cathepsin zymography was used to detect changes in levels of active cathepsins K, L, S, and V. Direct monocyte–endothelial cell co-cultures stimulated with TNFα generated maximally observed cathepsin K and V activities compared to either cell type alone (n = 3, p < 0.05) by a c-Jun N-terminal kinase (JNK)-dependent manner. Inhibition of JNK with SP6000125 blocked upregulation of cathepsin K activity by 49 % and cathepsin V by 81 % in endothelial cells. Together, these data show that inflammatory cues and monocyte–endothelial cell interactions upregulate cathepsin activity via JNK signaling axis and identify a new mechanism to target toward slowing the earliest stages of tissue remodeling in CVD.
KeywordsCathepsins Atherosclerosis Monocytes Endothelial cells Inflammation
The authors of this study would like to thank Eric Kopfle, Alex Miller, and Sindhuja Surapeneni for assistance with data collection. This work was funded by Georgia Tech startup funds and NIH New Innovator grant #1DP2OD007433-01 (MOP). The project described was supported by Award Number DP2OD007433 from the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the Director, National Institutes of Health or the National Institutes of Health. PMK was supported by an NSF graduate research fellowship.
- 5.Lutgens E, Lutgens SPM, Faber BCG, Heeneman S, Gijbels MMJ, de Winther MPJ, Frederik P, van der Made I, Daugherty A, Sijbers AM, Fisher A, Long CJ, Saftig P, Black D, Daemen MJAP, Cleutjens KBJM (2006) Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113(1):98–107. doi: 10.1161/CIRCULATIONAHA.105.561449 PubMedCrossRefGoogle Scholar
- 6.Platt MO, Ankeny RF, Shi G-P, Weiss D, Vega JD, Taylor WR, Jo H (2007) Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. Am J Physiol Heart Circ Physiol 292(3):H1479–H1486. doi: 10.1152/ajpheart.00954.2006 PubMedCrossRefGoogle Scholar
- 13.Tolosa E, Li W, Yasuda Y, Wienhold W, Denzin LK, Lautwein A, Driessen C, Schnorrer P, Weber E, Stevanovic S, Kurek R, Melms A, Bromme D (2003) Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J Clin Investig 112(4):517–526. doi: 10.1172/JCI18028 PubMedGoogle Scholar
- 15.Kitamoto S, Sukhova GK, Sun J, Yang M, Libby P, Love V, Duramad P, Sun C, Zhang Y, Yang X, Peters C, Shi G-P (2007) Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 115(15):2065–2075. doi: 10.1161/CIRCULATIONAHA.107.688523 PubMedCrossRefGoogle Scholar
- 19.Ruettger A, Schueler S, Mollenhauer JA, Wiederanders B (2008) Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes. J Biol Chem 283(2):1043–1051. doi: 10.1074/jbc.M704915200 PubMedCrossRefGoogle Scholar
- 20.Gacko MGS (1998) Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. Clin Chem 36:449–452Google Scholar
- 21.Burns-Kurtis CL, Olzinski AR, Needle S, Fox JH, Capper EA, Kelly FM, McQueney MS, Romanic AM (2004) Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit. Cardiovasc Res 62(3):610–620. doi: 10.1016/j.cardiores.2004.02.002 PubMedCrossRefGoogle Scholar
- 23.Abdul-Hussien H, Soekhoe RG, Weber E, von der Thusen JH, Kleemann R, Mulder A, van Bockel JH, Hanemaaijer R, Lindeman JH (2007) Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 170(3):809–817. doi: 10.2353/ajpath.2007.060522 PubMedCrossRefGoogle Scholar
- 27.Hui C, Like W, Yan F, Tian X, Qiuyan W, Lifeng H (2010) S-allyl-l-cysteine sulfoxide inhibits tumor necrosis factor-alpha induced monocyte adhesion and intercellular cell adhesion molecule-1 expression in human umbilical vein endothelial cells. Anat Rec (Hoboken) 293(3):421–430. doi: 10.1002/ar.21070 CrossRefGoogle Scholar